sulforaphane has been researched along with Kahler Disease in 2 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Excerpt | Relevance | Reference |
---|---|---|
"Multiple myeloma is a fatal disease characterized by clonal proliferation of plasma cells in the bone marrow." | 5.37 | Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. ( Anderson, KC; Blotta, S; Cervi, D; Cholujova, D; Daley, JF; Delmore, J; Hideshima, T; Jakubikova, J; Kim, K; Klippel, S; Leiba, M; McMillin, DW; Mitsiades, CS; Nahar, S; Negri, J; Ooi, M; Richardson, PG; Sedlak, J, 2011) |
"Multiple myeloma is a fatal disease characterized by clonal proliferation of plasma cells in the bone marrow." | 1.37 | Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. ( Anderson, KC; Blotta, S; Cervi, D; Cholujova, D; Daley, JF; Delmore, J; Hideshima, T; Jakubikova, J; Kim, K; Klippel, S; Leiba, M; McMillin, DW; Mitsiades, CS; Nahar, S; Negri, J; Ooi, M; Richardson, PG; Sedlak, J, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jakubikova, J | 1 |
Cervi, D | 1 |
Ooi, M | 1 |
Kim, K | 1 |
Nahar, S | 1 |
Klippel, S | 1 |
Cholujova, D | 1 |
Leiba, M | 1 |
Daley, JF | 1 |
Delmore, J | 1 |
Negri, J | 1 |
Blotta, S | 1 |
McMillin, DW | 1 |
Hideshima, T | 1 |
Richardson, PG | 1 |
Sedlak, J | 1 |
Anderson, KC | 1 |
Mitsiades, CS | 1 |
Doudican, NA | 1 |
Wen, SY | 1 |
Mazumder, A | 1 |
Orlow, SJ | 1 |
2 other studies available for sulforaphane and Kahler Disease
Article | Year |
---|---|
Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line; Cell Proliferation; Cell Survival; | 2011 |
Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Caspases, Initiator; Cell | 2012 |